Subsequently, a few novel studies have recently been performed to estimate the associations of MTHFR 677C>T polymorphism with risk of ovarian and cervical cancer and provide new evidences that were not included in the previous meta-analyses. This evidence concerns the gene MTHFR and cervical carcinoma.